相关实验视频
Updated: Jun 28, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.6K
对内分泌和炎症标记物的分析 维护比率 损伤螺旋法
Fabíola Ramos Jesus1, Anna Clara Santiago Moraes2, Ingrid Lorena Neves da Silva2
1Maternidade Climério de Oliveira (MCO/EBSERH), Universidade Federal da Bahia, Salvador 40055-150, Bahia, Brazil.
Medical sciences (Basel, Switzerland)
|April 23, 2024
概括
保持比率受损螺旋计 (PRISm) 和慢性阻塞性肺部疾病 (COPD) 的个体具有相似的低脱水氨 (DHEA) 水平. 肺功能不同,但内分泌特征在这些呼吸道疾病中表现出相似之处.
科学领域:
- 肺部医学 肺部医学
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及慢性气流阻塞.
- 保持比率损伤螺旋计 (PRISm) 可能表明未来的COPD风险.
- 了解PRISm和COPD超出肺功能是非常重要的.
研究的目的:
- 为了比较PRISm和COPD患者的免疫反应和内分泌特征.
- 为了识别除了螺旋计之外的差异和相似之处.
- 在PRISm中调查内分泌标记物,免疫标记物和肺功能之间的联系.
主要方法:
- 进行了临床评估和肺功能测试.
- 测量了血清激素水平和细胞因子度.
- 分析了免疫标记物 (IL-6,IL-8,IL-10,IL-12,TNF) 和内分泌标记物 (DHEA,DHEA-S).
主要成果:
- PRISM和COPD组在营养状况,肺功能和并发性疾病方面存在差异.
- 在PRISm和COPD之间没有发现IL-6,IL-8,IL-10,IL-12和TNF水平的显著差异.
- 与对照组相比,PRISm和COPD患者表现出较低的脱水氨固醇 (DHEA) 和脱水氨硫酸 (DHEA-S) 水平.
结论:
- PRISm和COPD患者的内分泌特征有相似的变化,特别是较低的DHEA和DHEA-S水平.
- 在PRISm和COPD中观察到DHEA-S/DHEA水平和FEV1/FVC之间的正相关性.
- 这项研究强调了共享的内分泌特征,尽管PRISm和COPD的肺功能不同.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
81
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
01:25Pulmonary Function Tests
329
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
329